In other cohorts tested for MSA, rates of calcinosis by MSA were rarely significant, with the exception of one that showed 75% of patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibodies developed calcinosis (16). This evidence concerns the gene IFIH1 and calcinosis.